Newsroom
153 articles
Featured Adults with cerebrotendinous xanthomatosis (CTX) can now be treated with Ctexli (chenodiol), which is approved by the US Food and Drug Administration. Also, it’s The first FDA-approved medication…
Featured For the purpose of improving glycemic control in adults and pediatric patients with diabetes mellitus, the U.S. Food and Drug Administration authorized Merilog (insulin-aspart-szjj) as a biosimilar to…
Featured In order to provide vital safety alerts, the U.S. Food and Drug Administration is warning patients about a safety issue with diabetic devices that rely on smartphones, including…
Featured Nemolizumab, also known as Nemluvio, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat moderate to severe prurigo nodularis in adults aged 18…
Featured The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of gozetotide (marketed under the name Illuccix) in a positioning emission tomography (PET) scan, a form…
Featured The MHRA has authorized the chikungunya vaccine (live) (brand name IXCHIQ) to prevent adults from chikungunya disease, which is caused by the chikungunya virus (CHIKV). CHIKV is spread…
Featured The Medicines and Healthcare Products Regulatory Agency (MHRA) has opened a consultation on regulatory guidance for personalized mRNA cancer immunotherapies (also known as cancer vaccines). This is a…
Featured The EMA’s human medicines committee (CHMP) has issued a good scientific opinion on Ivermectin/Albendazole for the treatment of illnesses caused by a variety of worm parasites, including lymphatic…
Featured The widespread use of azole fungicides (azoles), notably in some agricultural and horticultural operations, raises the possibility of Aspergillus fungus acquiring resistance to critical antifungal treatments. This noteworthy…
Featured The FDA has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx alleviates pain by inhibiting…
Featured The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved garadacimab (brand name Andembry) for the prevention of angioedema attacks in individuals aged 12 and up with hereditary…
Featured If approved, the United States would be the world’s first government to adopt such a bold, life-saving step to prevent and decrease smoking-related disease and death. The FDA…
Featured Extra safety information is being added to all montelukast products, Montelukast is a prescription medicine used to prevent and treat chronic asthma in adults and children aged 2…
Featured New approval by the Medicines and Healthcare products Regulatory Agency (MHRA) of the medicine sotatercept (Winrevair) to treat pulmonary arterial hypertension (PAH). Sotatercept is used, in combination with…
Featured The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved tarlatamab (Imdylltra) as a treatment for adult patients with small cell lung cancer (SCLC) that has progressed to…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP